Renumathy Dhanasekaran
Stanford University(US)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Cancer Genomics and Diagnostics, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma(2017)2,502 cited
- → The MYC oncogene — the grand orchestrator of cancer growth and immune evasion(2021)911 cited
- → Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study(2020)520 cited
- → High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry(2020)270 cited
- → Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study(2020)251 cited
- → Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study(2020)235 cited
- → Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)(2010)219 cited
- → Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances(2016)212 cited
- → Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy(2018)206 cited
- → Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver(2024)202 cited